[1]
“A retrospective analysis of 47 procedures using a bioresorbable polycaprolactone based injectable for the treatment of mild to moderate stress urinary incontinence in adult females”, UIJ, vol. 34, no. 1, Jun. 2022, doi: 10.4081/uij.2022.283.